Pro/antioxidant status of isolated human blood lymphocytes treated with a newly synthesized compound D11-(furan-2-yl)-9-hydroxy-3,11-dihydro-2H-benzo[6,7]thiochromeno[2,3-d]thiazole-2,5,10-trione
The Ukrainian Biochemical Journal · 20.04.2026 · 98 (2) · 76-84
DOI: 10.15407/ubj98.02.076 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Ukrainian Biochemical Journal, online erschienen am 20.04.2026. Verfasst von О. P. Sen und 6 weiteren Autor:innen.
Abstract (Originalsprache)
It is known that 1,4-naphthoquinone derivatives form the basis of a wide range of pharmaceuticals with diverse biological activities. A newly synthesized compound of this group – 11-(furan-2-yl)-9-hydroxy-3,11-dihydro-2H-benzo[6,7]thiochromeno[2,3-d]thiazole-2,5,10-trione, designated by Les-6400 laboratory code, is noteworthy for its drug-like properties. The aim of the study was to determine the parameters of glutathione antioxidant system in isolated human peripheral blood lymphocytes treated with Les-6400. Saponin-permeabilized lymphocytes from the blood samples of healthy male volunteers aged 20–44 years were used in the study. A significant dose-dependent increase in the lipid peroxidation process was observed upon lymphocytes exposure to Les-6400 at concentrations of 10–5–10–3 M. At the concentrations studied no effect of Les-6400 on GSH level was observed, while in the 10–4–10–3 M concentration range the activity of glutathione antioxidant enzymes was markedly affected: the activity of both glutathione peroxidase and glutathione reductase was increased, while that of glutathione-S-transferase was reduced. Thus, Les-6400 had a pronounced effect on the pro/antioxidant status of blood lymphocytes. Keywords: 1, 4-naphthoquinone derivative, glutathione peroxidase, glutathione reductase, glutathione-S-transferase, lipid peroxidation, lymphocytes
Zitieren
APA
Sen, О. P., Оnufrovych, О. K., Kushynska, M. Y., Pershyn, О. I., Besedina,, А. S., Fafula, R. V., & Vorobets, Z. D. (2026). Pro/antioxidant status of isolated human blood lymphocytes treated with a newly synthesized compound D11-(furan-2-yl)-9-hydroxy-3,11-dihydro-2H-benzo[6,7]thiochromeno[2,3-d]thiazole-2,5,10-trione. The Ukrainian Biochemical Journal, 98(2), 76-84. https://doi.org/10.15407/ubj98.02.076
Vancouver
Sen ОP, Оnufrovych ОK, Kushynska MY, Pershyn ОI, Besedina, АS, Fafula RV, et al. Pro/antioxidant status of isolated human blood lymphocytes treated with a newly synthesized compound D11-(furan-2-yl)-9-hydroxy-3,11-dihydro-2H-benzo[6,7]thiochromeno[2,3-d]thiazole-2,5,10-trione. The Ukrainian Biochemical Journal. 2026;98(2):76-84. doi:10.15407/ubj98.02.076
BibTeX
@article{Sen2026,
author = {Sen, О. P. and Оnufrovych, О. K. and Kushynska, M. Ye. and Pershyn, О. I. and Besedina,, А. S. and Fafula, R. V. and Vorobets, Z. D.},
title = {Pro/antioxidant status of isolated human blood lymphocytes treated with a newly synthesized compound D11-(furan-2-yl)-9-hydroxy-3,11-dihydro-2H-benzo[6,7]thiochromeno[2,3-d]thiazole-2,5,10-trione},
journal = {The Ukrainian Biochemical Journal},
year = {2026},
volume = {98},
number = {2},
pages = {76--84},
doi = {10.15407/ubj98.02.076}
}
EUVIMED